Synthesis and in Vitro and in Vivo Characterization of Highly β(1)-Selective β-Adrenoceptor Partial Agonists

[Image: see text] β-Adrenoceptor antagonists boast a 50-year use for symptomatic control in numerous cardiovascular diseases. One might expect highly selective antagonists are available for the human β-adrenoceptor subtype involved in these diseases, yet few truly β(1)-selective molecules exist. To...

Descripción completa

Detalles Bibliográficos
Autores principales: Mistry, Shailesh N., Baker, Jillian G, Fischer, Peter M, Hill, Stephen J, Gardiner, Sheila M, Kellam, Barrie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2013
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694353/
https://www.ncbi.nlm.nih.gov/pubmed/23614528
http://dx.doi.org/10.1021/jm400348g

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3694353/
https://www.ncbi.nlm.nih.gov/pubmed/23614528
http://dx.doi.org/10.1021/jm400348g

Ejemplares similares